Regulatory T cells require peripheral CCL2-CCR2 signaling to facilitate the resolution of medication overuse headache-related behavioral sensitization

Sun Ryu,Jintao Zhang,Roli Simoes,Xuemei Liu,Zhaohua Guo,Li Feng,Jacqueline Unsinger,Richard S. Hotchkiss,Yu-Qing Cao
DOI: https://doi.org/10.1186/s10194-024-01900-5
2024-11-13
The Journal of Headache and Pain
Abstract:Medication overuse headache (MOH) is the most common secondary headache disorder, resulting from chronic and excessive use of medication to treat headaches, for example, sumatriptan. In a recent study, we have shown that the peripheral C-C motif ligand 2 (CCL2), C-C motif chemokine receptor 2 (CCR2) and calcitonin-gene-related peptide (CGRP) signaling pathways interact with each other and play critical roles in the development of chronic migraine-related behavioral and cellular sensitization. In the present study, we investigated whether CCL2-CCR2 and CGRP signaling pathways play a role in the development of sumatriptan overuse-induced sensitization, and whether they are involved in its resolution by the low-dose interleukin-2 (LD-IL-2) treatment.
neurosciences,clinical neurology
What problem does this paper attempt to address?